Articles of Association for Genmab A/S
June 14, 2016 09:34 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated June 9, 2016. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Tildeling af warrants til medarbejdere i Genmab
June 09, 2016 12:51 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 9. juni 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) offentliggjorde i dag, at på et bestyrelsesmøde har bestyrelsen besluttet at tildele 16.800 warrants...
Grant of Warrants to Genmab Employees
June 09, 2016 12:51 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; June 9, 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to issue 16,800 warrants to employees of the...
Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis
June 02, 2016 01:43 ET
|
Genmab A/S
Company Announcement
Phase III trials (ASCLEPIOS I and II) with the subcutaneous formulation of ofatumumab in Relapsing Multiple Sclerosis
Studies expected to begin enrolling in September...
Genmab offentliggør fase III studier med ofatumumab til behandling af recidiverende multipel sklerose
June 02, 2016 01:43 ET
|
Genmab A/S
Selskabsmeddelelse
Fase III studier (ASCLEPIOS I og II) med den subkutane formulering af ofatumumab til behandling af recidiverende multipel sklerose
Indrullering af patienter til...
Genmabs samlede antal stemmerettigheder og samlede aktiekapital
May 31, 2016 11:05 ET
|
Genmab A/S
København, Danmark, 31. maj 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) skal i henhold til § 10 i bekendtgørelse nr. 1258 af 9. november 2015 om udstederes oplysningsforpligtelser hermed meddele, at...
Genmab’s Total Number of Voting Rights and Total Share Capital
May 31, 2016 11:05 ET
|
Genmab A/S
Copenhagen, Denmark; May 31, 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) announces that pursuant to section 10 of Executive Order no. 1258 of November 9, 2015 on Issuers' Disclosure Obligations, the...
Genmab to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
May 31, 2016 03:16 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; May 31, 2016 – Genmab A/S (OMX: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs 37th Annual...
Genmab præsenterer ved den 37. årlige Goldman Sachs Global Healthcare konference
May 31, 2016 03:16 ET
|
Genmab A/S
Pressemeddelelse
København, Danmark, 31. maj 2016 – Genmab A/S (OMX: GEN) offentliggjorde i dag, at selskabets CEO, Jan van de Winkel, ph.d., vil give en præsentation om Genmab ved den 37. årlige...
Genmab Achieves USD 30 Million Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
May 30, 2016 10:56 ET
|
Genmab A/S
Company Announcement
Genmab to receive USD 30 million milestone payment from Janssen
Milestone triggered by first commercial sale of DARZALEX in Europe
Copenhagen, Denmark; May 30, 2016...